PI 3-kinase p110β: A new target for antithrombotic therapy

Full text for this resource is not available from the Research Repository.

Jackson, SP, Schoenwaelder, SM, Goncalves, I, Nesbitt, WS, Yap, CL, Wright, CE, Kenche, V, Anderson, KE, Dopheide, SM, Yuan, Y, Sturgeon, SA, Prabaharan, H, Thompson, PE, Smith, GD, Shepherd, PR, Daniele, N, Kulkarni, S, Abbott, B, Saylik, D, Jones, C, Lu, Sai ORCID: 0000-0002-6368-3721, Giuliano, S, Hughan, SC, Angus, JA, Robertson, AD and Salem, HH (2005) PI 3-kinase p110β: A new target for antithrombotic therapy. Nature Medicine, 11 (5). 507 - 514. ISSN 1078-8956

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/36294
DOI https://doi.org/10.1038/nm1232
Official URL https://www.nature.com/articles/nm1232
Subjects Historical > FOR Classification > 1102 Cardiorespiratory Medicine and Haematology
Current > Division/Research > College of Health and Biomedicine
Keywords phosphoinositide 3-kinase; platelet function; thrombosis
Citations in Scopus 495 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login